Oba Jane, Carvalho Werther Brunow de, Silva Clovis Artur, Delgado Artur Figueiredo
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Einstein (Sao Paulo). 2020;18:eRW5774. doi: 10.31744/einstein_journal/2020rw5774. Epub 2020 Jul 10.
Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted through the digestive system, the so-called fecal-oral route of transmission, and may induce several gastrointestinal manifestations. MEDLINE® and Embase databases were extensively searched for major clinical manifestations of gastrointestinal involvement in children and adolescents with COVID-19 reported in medical literature, and for nutritional therapy-related data. Findings and recommendations were pragmatically described to facilitate overall pediatric approach. A total of 196 studies addressing gastrointestinal or nutritional aspects associated with the global COVID-19 pandemic were found. Of these, only 17 focused specifically on pediatric patients with regard to aforementioned gastrointestinal or nutritional aspects. Most articles were descriptive and six addressed guidelines, established protocols, or expert opinions. Children and adolescents with gastrointestinal symptoms, such as nausea, vomiting and diarrhea, should be seriously suspected of COVID-19. Gastrointestinal signs and symptoms may occur in 3% to 79% of children, adolescents and adults with COVID-19, and are more common in severe cases. These include diarrhea (2% to 50%), anorexia (40% to 50%), vomiting (4% to 67%), nausea (1% to 30%), abdominal pain (2% to 6%) and gastrointestinal bleeding (4% to 14%). Patients with inflammatory bowel disease or chronic liver disease are not at greater risk of infection by SARS-CoV-2 relative to the general population. Nutritional support plays an important role in treatment of pediatric patients, particularly those with severe or critical forms of the disease. The digestive system may be a potential route of COVID-19 transmission. Further research is needed to determine whether the fecal-oral route may be involved in viral spread. Nutritional therapy is vital to prevent malnutrition and sarcopenia in severe cases.
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种疾病,已在全球大流行。越来越多的证据表明,SARS-CoV-2可通过消化系统传播,即所谓的粪口传播途径,并可能引发多种胃肠道表现。我们广泛检索了MEDLINE®和Embase数据库,以查找医学文献中报道的COVID-19儿童和青少年胃肠道受累的主要临床表现以及营养治疗相关数据。对研究结果和建议进行了实用的描述,以促进整体儿科治疗方法。共发现196项涉及与全球COVID-19大流行相关的胃肠道或营养方面的研究。其中,只有17项专门针对上述胃肠道或营养方面的儿科患者。大多数文章为描述性文章,有6篇涉及指南、既定方案或专家意见。有恶心、呕吐和腹泻等胃肠道症状的儿童和青少年应被高度怀疑感染COVID-19。胃肠道体征和症状可能出现在3%至79%的COVID-19儿童、青少年和成人中,在重症病例中更为常见。这些症状包括腹泻(2%至50%)、厌食(40%至50%)、呕吐(4%至67%)、恶心(1%至30%)、腹痛(2%至6%)和胃肠道出血(4%至14%)。炎症性肠病或慢性肝病患者感染SARS-CoV-2的风险并不高于普通人群。营养支持在儿科患者的治疗中起着重要作用,尤其是那些患有重症或危重症的患者。消化系统可能是COVID-19的潜在传播途径。需要进一步研究以确定粪口途径是否可能参与病毒传播。营养治疗对于预防重症病例中的营养不良和肌肉减少症至关重要。